Abstracts 1

  1. Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency.
    Pytel KM et al.,The British Society of Gene Therapy Annual Conference (2016)

 

E.coli from a large scale industrial production of our clinical trial plasmid pGM169.